Literature DB >> 11532140

Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection.

H C Gérard1, B Krausse-Opatz, Z Wang, D Rudy, J P Rao, H Zeidler, H R Schumacher, J A Whittum-Hudson, L Köhler, A P Hudson.   

Abstract

During persistent infection, the intracellular bacterial pathogen Chlamydia trachomatis is viable but severely attenuates the production of new, infectious elementary bodies (EBs). To investigate the reasons for this lack of new EB output, we analysed the expression of chlamydial genes encoding products required for DNA replication and cell division, using in vitro models of active versus persistent infection and synovial tissue samples from patients with chronic Chlamydia-associated arthritis. Hep-2 cells were infected with K serovar C. trachomatis and harvested at t = 0-48 h post-infection (p.i; active). Human monocytes were infected similarly and harvested at t = 1-7 days p.i. (persistent). RNA preparations from infected/uninfected cells and patient samples were subjected to reverse transcription-polymerase chain reaction (RT-PCR) targeting polA, dnaA, mutS and parB mRNA, related to chlamydial DNA replication/segregation; these were expressed in infected Hep-2 cells from 11 to 48 h p.i; ftsK and ftsW, related to cell division, were expressed similarly. Real-time PCR analyses demonstrated that significant accumulation of chlamydial chromosome began at about 12 h p.i. in infected Hep-2 cells. In infected human monocytes, polA, dnaA, mutS and parB mRNA were produced from days 1-7 p.i. and were weakly expressed in patient samples. Real-time PCR indicated the continuing accumulation of chlamydial chromosome during the 7 day monocyte infection, although the rate of such accumulation was lower than that occurring during active growth. However, transcripts from ftsK and ftsW were detected only at 1 day p.i. in infected monocytes but not thereafter, and they were absent in all patient samples. Thus, genes whose products are required for chlamydial DNA replication are expressed during persistence, but transcription of genes whose products are required for cytokinesis is severely downregulated. These data explain, at least in part, the observed attenuation of new EB production during chlamydial persistence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532140     DOI: 10.1046/j.1365-2958.2001.02550.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  36 in total

1.  Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation.

Authors:  Robert J Belland; David E Nelson; Dezso Virok; Deborah D Crane; Daniel Hogan; Daniel Sturdevant; Wandy L Beatty; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

Review 2.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Chlamydia trachomatis heat shock proteins 60 and 10 induce apoptosis in endocervical epithelial cells.

Authors:  Rajneesh Jha; Harsh Vardhan; Sylvette Bas; Sudha Salhan; Aruna Mittal
Journal:  Inflamm Res       Date:  2010-08-05       Impact factor: 4.575

4.  Beyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and Reactivation.

Authors:  Matthew K Muramatsu; Julie A Brothwell; Barry D Stein; Timothy E Putman; Daniel D Rockey; David E Nelson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

5.  Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response.

Authors:  Sanghamitra Mukhopadhyay; Richard D Miller; Erin D Sullivan; Christina Theodoropoulos; Sarah A Mathews; Peter Timms; James T Summersgill
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatis.

Authors:  Birgit Krausse-Opatz; Annette Busmann; Harald Tammen; Christoph Menzel; Thomas Möhring; Nicolas Le Yondre; Cornelia Schmidt; Peter Schulz-Knappe; Henning Zeidler; Hartmut Selle; Lars Köhler
Journal:  Med Microbiol Immunol       Date:  2007-01-06       Impact factor: 3.402

7.  Chlamydia trachomatis persistence in vitro: an overview.

Authors:  Priscilla B Wyrick
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

8.  Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.

Authors:  K Hokynar; S Korhonen; P Norja; J Paavonen; M Puolakkainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-14       Impact factor: 3.267

9.  Rsf1p, a protein required for respiratory growth of Saccharomyces cerevisiae.

Authors:  Lin Lu; George Roberts; Kirk Simon; Jia Yu; Alan P Hudson
Journal:  Curr Genet       Date:  2003-05-07       Impact factor: 3.886

10.  Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain.

Authors:  Ute Dreses-Werringloer; Mohammad Bhuiyan; Yinghao Zhao; Hervé C Gérard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Med Microbiol       Date:  2008-09-30       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.